ASH ASHLAND INC.
Wholesale-Chemicals & Allied Products · NYSE · SEC CIK 1674862 · Fiscal year ends 09/30
Financial factors as of 2026-06-30 (2026Q3), TTM = sum of the last four quarters
Growth
TTM revenue YoY-1.4%
TTM net income YoY106.0%
TTM EPS YoY105.7%
Revenue 3-yr CAGR-7.2%
Net income 3-yr CAGR-39.8%
Margins
Gross margin31.5%
Operating margin7.4%
Net margin2.8%
FCF margin13.6%
EBITDA margin16.1%
Returns
ROE2.8%
ROA1.1%
ROIC (approx.)2.8%
Asset turnover0.40x
Leverage & solvency
Liabilities / assets59.2%
Debt / equity0.73x
Current ratio3.05x
Interest coverage—
Cash quality & payout
Operating cash flow / net income6.44x
Accruals ratio-6.2%
Payout ratio146.2%
Capex / revenue4.6%
Factor history charts and full statement history on Pro 🔒
Financial statements
| Line item | FY2025*2025-09-30 | FY2024*2024-09-30 | FY2023*2023-09-30 | FY2022*2022-09-30 | FY2021*2021-09-30 |
|---|---|---|---|---|---|
| Income statement | |||||
| Revenue | $1.82B | $2.11B | $2.19B | $2.39B | $2.11B |
| Cost of revenue | $1.27B | $1.50B | $1.52B | $1.56B | $1.44B |
| Gross profit | $549.00M | $618.00M | $668.00M | $830.00M | $670.00M |
| R&D expense | $54.00M | $55.00M | $51.00M | $55.00M | $50.00M |
| SG&A expense | $344.00M | $404.00M | $365.00M | $393.00M | $358.00M |
| Operating income | -$775.00M | -$26.00M | $172.00M | $333.00M | $192.00M |
| Interest expense | $61.00M | $53.00M | $54.00M | $62.00M | $69.00M |
| Pretax income | -$809.00M | -$24.00M | $160.00M | $206.00M | $135.00M |
| Income tax | $13.00M | -$223.00M | -$8.00M | $25.00M | -$38.00M |
| Net income | -$845.00M | $169.00M | $178.00M | $927.00M | $220.00M |
| EBITDA | -$538.00M | $248.00M | $415.00M | $574.00M | $436.00M |
| EPS (basic) | -18.23 | 3.40 | 3.36 | 16.71 | 3.63 |
| EPS (diluted) | -18.23 | 3.36 | 3.31 | 16.41 | 3.59 |
| Dividends declared per share | 1.64 | 1.58 | 1.44 | 1.27 | 1.15 |
| Weighted avg. shares (diluted) | 46.00M | 50.00M | 54.00M | 56.00M | 61.00M |
| Banking | |||||
| Net interest income | -$33.00M | $24.00M | -$6.00M | -$149.00M | -$56.00M |
| Balance sheet | |||||
| Cash & equivalents | $215.00M | $300.00M | $417.00M | $646.00M | $210.00M |
| Receivables | $242.00M | $243.00M | $338.00M | $402.00M | $369.00M |
| Inventory | $568.00M | $545.00M | $626.00M | $629.00M | $473.00M |
| Current assets | $1.21B | $1.20B | $1.51B | $1.77B | $1.72B |
| PP&E, net | $1.20B | $1.30B | $1.37B | $1.34B | $1.43B |
| Goodwill | $705.00M | $1.38B | $1.36B | $1.31B | $1.43B |
| Intangibles | $563.00M | $751.00M | $886.00M | $963.00M | $1.10B |
| Total assets | $4.61B | $5.64B | $5.94B | $6.21B | $6.61B |
| Current liabilities | $423.00M | $490.00M | $456.00M | $553.00M | $934.00M |
| Short-term debt | $0 | $0 | $0 | $0 | $9.00M |
| Long-term debt | $1.38B | $1.35B | $1.31B | $1.27B | $1.60B |
| Total debt | $1.38B | $1.35B | $1.31B | $1.27B | $1.60B |
| Total liabilities | $2.71B | $2.78B | $2.84B | $2.99B | $3.86B |
| Shareholders' equity | $1.90B | $2.87B | $3.10B | $3.22B | $2.75B |
| Net debt | $1.17B | $1.05B | $897.00M | $624.00M | $1.40B |
| Cash flow statement | |||||
| Operating cash flow | $134.00M | $462.00M | $294.00M | $193.00M | $466.00M |
| Capital expenditure | $98.00M | $137.00M | $170.00M | $113.00M | $105.00M |
| Free cash flow | $36.00M | $325.00M | $124.00M | $80.00M | $361.00M |
| Investing cash flow | -$3.00M | -$51.00M | -$109.00M | -$102.00M | -$367.00M |
| Financing cash flow | -$179.00M | -$479.00M | -$371.00M | -$896.00M | -$426.00M |
| Depreciation & amortization | $237.00M | $274.00M | $243.00M | $241.00M | $244.00M |
| Stock-based compensation | $14.00M | $15.00M | $22.00M | $18.00M | $15.00M |
| Dividends paid | $76.00M | $78.00M | $76.00M | $70.00M | $70.00M |
| Share buybacks | $100.00M | $380.00M | $300.00M | $200.00M | $450.00M |
Free plan shows the latest 5 periods; Pro shows all 12 🔒
· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.
Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-18 06:30.